Dr Eve Hanks is the CEO & Founder of MI:RNA. She is a veterinary surgeon with an advanced certificate in medicine and a PhD in immunology. Eve is responsible for the conception and innovation of the technology at MI:RNA. Eve guides the team on strategy, investment and fundraising, as well as partnerships and commercialisation of the MI:RNA diagnostic platform. Eve is a dynamic and committed scientist who strives to build great products by harnessing ground-breaking innovation. She leads a gender balanced team of experts within a high growth, purpose-led company.